P021
Peptide 021, GLXC-21260
A tetrapeptide derived from CNTF, designed to promote neurogenesis, enhance cognition, and mitigate Alzheimer's pathologies by modulating neurotrophic signaling.
Completed
PHASE1, PHASE2
NCT02039674
A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)
Merck Sharp & Dohme LLC
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00537017
Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
Merck Sharp & Dohme LLC
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT03894709
A Care Model for Elderly Hip-fractured Persons With Cognitive Impairment and Their Family Caregivers
Chang Gung Memorial Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT00477815
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
Mayo Clinic
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE2
NCT03104439
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT03747107
Pharmacist and Data Driven Quality Improvement in Primary Care
University of Dundee
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00084604
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06622395
Telepsychiatry in Children: Diagnostic Evaluation of Autism Spectrum Disorder
Centre Hospitalier St Anne
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT02237521
The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease
Bo Feldt-Rasmussen
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT03310619
A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies
Celgene
INTERVENTIONAL
Updated Dec 15, 2025
Not Yet Recruiting
NCT07168447
Transfusion Exchanges and Cognition in Sickle Cell Disease
Centre Hospitalier St Anne
OBSERVATIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT04793958
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Mirati Therapeutics Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT06729606
Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
National Institute of Allergy and Infectious Diseases (NIAID)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00703755
A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.
Solvay Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00703976
Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer
University of Pittsburgh
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT05892146
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01646255
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
UCB Pharma
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01996865
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Celgene
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT01038167
A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults
Vertex Pharmaceuticals Incorporated
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT00844285
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
UCB BIOSCIENCES, Inc.
OBSERVATIONAL
Updated Dec 15, 2025